The global blood transfusion market is expanding steadily, fueled by the growing prevalence of chronic diseases, an aging population, and rising surgical procedures. North America continues to dominate due to advanced healthcare infrastructure and higher surgical volumes.

The blood transfusion market was valued at USD 7.1 Billion in 2024 and is projected to grow from USD 7.53 Billion in 2025 to reach USD 12 Billion by 2033, reflecting a CAGR of 6% during the forecast period (2025–2033). Blood transfusion is a critical procedure where blood or its components are transferred intravenously to treat conditions such as anemia, sickle cell disease, hemophilia, cancer, and trauma.

📥 Download Sample Report

Market Drivers

One of the strongest growth drivers is the increasing burden of chronic diseases worldwide. Conditions like cardiovascular diseases, cancer, diabetes, and anemia are steadily rising across all regions. For instance, cancer alone caused an estimated 9.6 million deaths globally in 2018, making it the second leading cause of death according to WHO. Such health conditions often require transfusions to maintain adequate blood levels.

Another key factor is the growing number of road accidents and surgical procedures. WHO reports that around 1.35 million people die annually in road crashes, while up to 50 million suffer non-fatal injuries. In the U.S. alone, outpatient surgical procedures are expected to increase from 129 million in 2018 to 144 million by 2023. Both emergency and planned surgeries continue to create high demand for blood transfusions.

Regional Insights

North America dominates the market, backed by an aging population, higher chronic disease rates, and robust healthcare spending. According to the U.S. Department of Health & Human Services, lifestyle factors such as smoking, alcohol consumption, and lack of physical activity drive chronic illnesses in the region. Additionally, over 2.35 million people are injured in road crashes annually, further supporting the need for blood transfusion services.

Product Insights

The market is segmented into:

  • Blood Bag and Accessory

  • Blood Mixer

  • Blood Component Separator

  • Apheresis Device

  • Pathogen Reduction System

  • Consumables and Supplies

  • Others

Among these, the pathogen reduction system is expected to witness the fastest growth. This technology improves transfusion safety by lowering the risk of infections from pathogens like viruses and bacteria, making it increasingly valuable in modern healthcare.

Key Players in the Blood Transfusion Market

  • Grifols S.A. (Spain)

  • Immucor Inc. (US)

  • Ortho Clinical Diagnostics (US)

  • Abbott Laboratories (US)

  • Bio-Rad Laboratories, Inc. (US)

  • Hoffmann-La Roche Ltd. (Switzerland)

  • Quotient Ltd. (Switzerland)

  • BD (US)

  • Terumo Corporation (Japan)

  • Braun (Germany)

These companies are at the forefront of innovation, focusing on safety, automation, and expanding global access to transfusion products.

Market Segmentation

By Product: Blood Bag and Accessory, Blood Mixer, Blood Component Separator, Apheresis Device, Pathogen Reduction System, Consumables and Supplies, Others
By End-User: Hospitals, Blood Bank, Ambulatory Surgical Centers, Others
By Region: North America, Europe, Asia-Pacific, Middle East and Africa, Latin America

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/